Profiling Autoreactive IgG, IgM, IgA and IgE Antibodies in System Lupus Erythematosus Patients Using Antigen Microarrays

Quanzhen Li,Junxia Wei,Chengsong Zhu,Hui Luo
DOI: https://doi.org/10.4049/jimmunol.212.supp.1034.4616
2024-01-01
The Journal of Immunology
Abstract:Abstract OmicsArray™ antigen microarrays bearing 120 antigens were used for profiling IgG, IgM, IgA and IgE autoantibodies in 240 well defined SLE patients and matched healthy controls (HCs). Our analysis show that the average number of positive IgG autoantibodies in SLE is 28.5 with over 95% of SLE patients harbor 5 or more autoantibodies, comparing with 3 positive IgG Autoantibodies in HCs with 25% have 5 or more autoantibodies (p<0.05). A group of 19 IgG autoantibodies targeting to various nuclear antigens (dsDNA, chromatin, histone, Sm/RNP, PCNA, CENP-B, etc.) were significantly enriched in SLE by clustering analysis. The presence of IgG autoantibodies against DNA-associated antigens were most significantly associated with disease activity (SLEDAI) and lupus nephritis (r=0.56, p<0.001) in SLE. The IgG autoantibodies which are positive in HCs were mostly those targeting non-nuclear antigens, such as collagens, alpha-actinin, heparin and cardiolipin. However, some ANA positive HCs exhibited higher IgM specificities targeting to both non-nuclear and nuclear antigens whereas in SLE the IgM autoAb reaction were relatively lower. IgA autoantibodies were detected in over 50% of SLE patients, preferentially targeting to DNA- and RNA-associated antigens indicating the high prevalence of IgA autoantibodies may play a role in SLE. IgE autoantibodies were not detectable for most autoantigens except about 15% of SLE patients showed positive IgE autoantibodies to a small subset of DNA antigens.
What problem does this paper attempt to address?